borderline significantp = 0.05
In the final month, the difference in chemotherapy use is borderline significant (8.5% in males and 6.6% in females; p = 0.05). 3.4.
In the final month, the difference in chemotherapy use is borderline significant (8.5% in males and 6.6% in females; p = 0.05). 3.4.